Mutations of TP53 (point mutations or deletions) lead to the production of aberrant proteins that not only lose their tumor-suppressive functions but also frequently act as driver oncogenes that promote malignant progression, invasion, and metastasis [87]. This evidence concerns the gene TP53 and neoplasm.